Navigation Links
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
Date:3/7/2013

venture fund) on a timely basis or at all; we may need to modify the nature and level of our investments and capital expenditures; we may not maintain our preferred provider status with our clients and may be unable to successfully expand our capabilities to meet client needs; our intellectual property protection policies may be breached, harming our customers and us; and we may face increased margin pressure as a result of renminbi appreciation and increased labor inflation in China and the company's investment.  In addition, other factors that could cause our actual results to differ from what we currently anticipate include failure to generate sufficient future cash flows or to secure any required future financing on acceptable terms or at all; failure to retain key personnel; our reliance on a limited number of customers to continue to account for a high percentage of our revenues; the risk of payment failure by any of our large customers, which could significantly harm our cash flows and profitability; our dependence upon the continued service of our senior management and key scientific personnel, and our ability to retain our existing customers or expand our customer base.  You should read the financial information contained in this release in conjunction with the consolidated financial statements and related notes thereto included in our 2011 Annual Report on Form 20-F filed with the Securities and Exchange Commission and available on the Securities and Exchange Commission's website at http://www.sec.gov.  For additional information on these and other important factors that could adversely affect our business, financial condition, results of operations and prospects, see "Risk Factors" beginning on page 6 of our 2011 Annual Report on Form 20-F.  Our results of operations for fourth-quarter 2012 are not necessarily indicative of our operating results for any future periods.  All projections in this rel
'/>"/>
SOURCE Wuxi PharmaTech Co. Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies
2. WuXi PharmaTech Schedules Fourth-Quarter 2012 Earnings Release
3. WuXi PharmaTech Presents the 2012 Life Science and Chemistry Awards
4. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2012 Annual General Meeting
5. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
6. WuXi PharmaTech and Open Monoclonal Technology Announce OmniRat(TM) Antibody Collaboration
7. WuXi PharmaTech to Manufacture Ibalizumab for TaiMed Biologics
8. WuXi PharmaTech Receives GLP Certificate from SFDA for Suzhou Toxicology Facility
9. WuXi PharmaTech Announces Second-Quarter 2012 Results
10. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
11. WuXi PharmaTech Announces First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... CHICAGO, Ill. , June 1, 2015  AbbVie ... 2015 Healthcare Conference on Thursday, June 4, 2015. ... will participate in a question and answer session at ... webcast of the presentation will be accessible through AbbVie,s ... archived edition of the session will be available later ...
(Date:6/1/2015)... BOSTON , June 1, 2015 Symbiotix ... a $2.3 million Phase 2 Small Business Technology Transfer ... (NIH) National Institute of Allergy and Infectious Diseases (NIAID). ... is developing a novel class of molecular therapeutics ... lead clinical candidate, Polysaccharide A (PSA), is the first ...
(Date:6/1/2015)... N.J. , June 1, 2015  Elusys ... and Drug Administration (FDA) has accepted for filing ... Anthim® (obiltoxaximab) for the treatment and prevention of ... submitted on March 20, 2015. Anthim is a ... Stockpile, the U.S. government,s repository of critical medical ...
Breaking Medicine Technology:Symbiotix Biotherapies Announces $2.3 Million Award from NIH's National Institute of Allergy and Infectious Diseases (NIAID) 2U.S. Food And Drug Administration Accepts Biologics License Application For Anthim (Obiltoxaximab) 2U.S. Food And Drug Administration Accepts Biologics License Application For Anthim (Obiltoxaximab) 3
... NEW YORK, April 18, 2012 Financial executives in ... excise tax and the burden of its related compliance ... bottom lines, according to a survey conducted by KPMG ... of respondents said their companies are already contemplating actions ...
... NEW YORK, April 18, 2012 ... initiates coverage on Pacira Pharmaceuticals ... price target $18.00. ... is a member of the ...
Cached Medicine Technology:KPMG Survey: Medical Device Execs Say New Excise Tax Will Hit Their Company Bottom Lines Hard 2KPMG Survey: Medical Device Execs Say New Excise Tax Will Hit Their Company Bottom Lines Hard 3
(Date:6/1/2015)... The National Association of Professional Women ... 2015-2016 inductee into its VIP Professional Woman of the ... for leadership in safety, environment, health and emergency response. ... professional women, boasting more than 700,000 members and over ... Lourinda with this important honor,” said NAPW President Star ...
(Date:6/1/2015)... NY (PRWEB) June 02, 2015 ... Selma Tansey as a 2015-2016 inductee into ... recognized with this prestigious distinction for leadership in mental ... for professional women, boasting more than 700,000 members and ... present Selma with this important honor," said NAPW President ...
(Date:6/1/2015)... Austin, TX (PRWEB) June 01, 2015 ... LLC, to facilitate their investors IRA transactions. AdvantaIRA Trust, ... , Giving investors the ability to fund positions using ... choice to participate on a project, even if there ... 2. Provide an additional funding source for Carson and ...
(Date:6/1/2015)... Unlike most generator rental companies, which raise their rates by ... when the generator is in standby mode, WPP charges a ... or not. WPP also offers an offsite storage option — ... few hours — for companies that do not have the ... “Even minor business disruptions are very expensive for commercial and ...
(Date:6/1/2015)... Linda Kincaid, age 67, knew something was wrong. She constantly ... thought it was just a part of getting older, but ... After going to the doctor, she received a distressing diagnosis: ... might happen to her. , Linda is not alone. As ... each year. Valve disease involves damage to one or more ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Lourinda Willey, Owner and Principal of Lourinda R. Willey LLC, Into its VIP Professional Woman of the Year Circle 2Health News:NAPW Inducts Selma Tansey, Executive Director of Washington Communities Human Services, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Worldwide Power Products Offers “Budget Billing” Contingency Generator Rental Program; Guarantees Power for Peak of Hurricane Season and Beyond 2Health News:A New Online Resource for Those Living with Heart Valve Disease 2Health News:A New Online Resource for Those Living with Heart Valve Disease 3
... The chief executive officer of a health authority in St. ... faulty tests that may have affected the care of ... the Eastern Health Regional Authority agreed that Eastern Health could ... knew about the hormone receptor tests. ,'I regret ...
... agreed on a $5-billion initiative with major banks to retrofit ... first such enterprise to combat climate change. ,Former ... week with a summit in New York attended by mayors ... discuss climate change. ,Clinton's initiative launched on Wednesday ...
... President A.P.J. Abdul Kalam Thursday stressed on the necessity ... to increase neuro activities of mentally challenged people. ... of Manovikas Kendra, a premier rehabilitation and research institute ... going on worldwide and it will take five to ...
... offered their first insights at research on a group ... will serve as models of typical childhood development. ... Health study suggest that healthy children perform better on ... was particularly true among children from low-income families. ...
... found that chemical relaxers used to straighten hair are not ... among African-American women. ,Hair relaxers can enter the ... are not fully monitored by the Food and Drug Administration, ... study named Black Womens Health Study was conducted by a ...
... In order to makeup for the loss of the ... hospitals run by state governments , the railways and ... from them to make them profit making units. ... Hindustan Antibiotics Limited, Bengal Chemicals and Pharmaceuticals Limited, Hindustan ...
Cached Medicine News:Health News:Faulty Hormone Tests Compromised Healthcare Of Breast Cancer Patients 2Health News:World Cities Join Hands to Combat Climate Change 2Health News:Library Of Brains To Aid Study of Brain Development In Children 2Health News:Library Of Brains To Aid Study of Brain Development In Children 3Health News:Hair Relaxers Not Linked With Breast Cancer Risk 2Health News:Government Hospitals to the Rescue of Loss-making Pharma Companies 2
... SP Surgical Table combines innovation and design ... up to 1,000 lbs. You can safely ... normal and reverse orientation and have virtually ... patients.,The Amsco 3085 SP Table offers the ...
... 1st MPJ IMPLANT SYSTEM is a unique ... of the 1st metatarsal phalangeal joint resulting ... revision of a previous arthroplasty. The ... pain relief, superior function and longevity. ...
... part in our daily lives. But degenerative ... cause severe handicaps. A decisive consideration in ... to produce a reconstructed joint function that ... possible.,The cementless RM Finger System has proven ...
... important part in our daily lives. But ... can cause severe handicaps. A decisive consideration ... was to produce a reconstructed joint function ... nearly possible.,The cementless RM Finger System has ...
Medicine Products: